美国 · 股市与财经 · MarketWatch

Alector Enters Licensing Agreement With Genentech for Parkinson's Therapy

来源：MarketWatch · 美国 11 小时前

Alector entered into an exclusive global licensing agreement with Genetech, which will receive worldwide rights to develop and commercialize Alector's AL050 program.

在 MarketWatch 阅读全文登录后可收藏

MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.marketwatch.com)

Alector Enters Licensing Agreement With Genentech for Parkinson's Therapy

推荐阅读

Rubio Opens 4-Day NATO Tour in Iceland to Discuss Arctic Security

The final Disrupt Stage lineup: Three days of conversations you won’t hear anywhere outside of TechCrunch Disrupt 2026

Half of bond ETFs now show negative one-year returns

My partner and I always thought we agreed on money. Then, we moved in together.

Metaplanet reveals net income strategy to fuel Bitcoin accumulation

Stripe to expand stablecoin cards to over 100 countries by the end of the year

Alector Enters Licensing Agreement With Genentech for Parkinson's Therapy

分享

推荐阅读

Rubio Opens 4-Day NATO Tour in Iceland to Discuss Arctic Security

The final Disrupt Stage lineup: Three days of conversations you won’t hear anywhere outside of TechCrunch Disrupt 2026

Half of bond ETFs now show negative one-year returns

My partner and I always thought we agreed on money. Then, we moved in together.

Metaplanet reveals net income strategy to fuel Bitcoin accumulation

Stripe to expand stablecoin cards to over 100 countries by the end of the year